The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Completed · Phase 2
Conditions studied: Post Traumatic Stress Disorder
In brief
The Safety and Tolerability of COMP360 in Participants with Post-traumatic Stress Disorder
Key facts
- Study ID
- NCT05312151
- Run by
- COMPASS Pathways
- People needed
- 22
- Starts
- 2022-06-10
- Expected to finish
- 2024-02-12
- Last updated by the study team
- 2025-06-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Sunstone Therapies — Rockville, Maryland, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- Kings College London, Institute of Psychiatry, Psychology and Neurology — London, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.